Sonoma Biotherapeutics is developing engineered regulatory T cell (Treg) therapies to treat serious autoimmune and inflammatory diseases driven by an imbalanced immune system. Founded by pioneers in Treg biology and cell therapy, the company is employing proprietary platform technologies and approaches to develop a new generation of targeted Treg cell therapies designed to induce durable immune tolerance to treat and prevent autoimmune and inflammatory diseases. Sonoma Biotherapeutics is based in South San Francisco and Seattle.


People & HR

Operations

South San Francisco, CA, USA

Sonoma BioTherapeutics

Alix Ventures

BIOS Community

Leverage our network to build your career.

#### Welcome!

Thank you for joining Bios Network!

To help us best support you in your search, please take a few minutes to tell us about what you are looking for in your next role. We’ll use this information to connect you to relevant opportunities in the Bios network as they come up.

You can always update this information later.

Welcome to the Bios talent network

As our companies grow, they look to us to help them find the best talent.

Signal that you'd be interested in working with a Bios company to help us put the right opportunities at great companies on your radar. The choice to pursue a new career move is then up to you.

Join TechBio Companies Driving Patient Impact